MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells-Reference-Cited by-同舟云学术

MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells

Published:2016-10-12 Issue:46 Volume:7 Page:75118-75129
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Xu Ke¹,Shen Ke²,Liang Xin²,Li Yueqi²,Nagao Norio³,Li Jiyu⁴,Liu Jianwen²,Yin Peihao¹

Affiliation:

1. Central Laboratory, Putuo Hospital and Interventional Cancer Institute of Chinese Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, PR China

2. State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, PR China

3. Department of Life and Environmental Sciences, Prefectural University of Hiroshima, Shobara, 727-0023, Japan

4. Department of general surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, PR China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma;Cancers;2023-11-24

2. Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer;Cancer Cell International;2022-10-13

3. MicroRNA-139, an Emerging Gate-Keeper in Various Types of Cancer;Cells;2022-02-22

4. CircRNA PTPRM Promotes Non-Small Cell Lung Cancer Progression by Modulating the miR-139-5p/SETD5 Axis;Technology in Cancer Research & Treatment;2022-01

5. Cancer stem cells;Understanding Cancer;2022